Keefe, Bruyette & Woods raises Chemung Financial price target to $59 from $55

Published 21/07/2025, 14:36
Keefe, Bruyette & Woods raises Chemung Financial price target to $59 from $55

Investing.com - Keefe, Bruyette & Woods raised its price target on Chemung Financial (NASDAQ:CHMG) stock to $59.00 from $55.00 on Monday, while maintaining a Market Perform rating.

The financial services firm cited Chemung’s improved profitability outlook following strategic balance sheet restructuring. During the quarter, Chemung issued $45 million of subordinated debt and sold $245.5 million of available-for-sale securities at a $17.5 million loss to better position its balance sheet. The $251 million market cap company maintains a conservative debt-to-equity ratio of 0.46, as revealed by InvestingPro analysis.

Proceeds from these transactions have been used to pay down expensive funding and will support future loan growth. The firm noted that Chemung’s pre-provision net revenue missed expectations by $0.01, as strong net interest income was offset by higher expenses and slightly lower fees.

Chemung Financial shares declined 1.65% on Friday, underperforming the KRX index by 207 basis points. Year-to-date, the stock has gained 7.3%, outperforming the KRX by 4.8%. The stock currently trades at a P/E ratio of 22.75x and has maintained dividend payments for an impressive 52 consecutive years. InvestingPro analysis suggests the stock is currently trading above its Fair Value, with 6 additional exclusive insights available to subscribers.

While Keefe, Bruyette & Woods views the balance sheet restructuring positively for more profitable growth and improved capital levels, it maintained its Market Perform rating based on near-term profitability outlook, despite acknowledging positive underlying trends in credit quality, loan pipeline, and asset repricing opportunities supporting net interest margin.

In other recent news, Chemung Financial has reported earnings that exceeded expectations, primarily due to lower-than-anticipated operating expenses. The company’s core earnings per share (EPS) outperformed projections, as highlighted by Piper Sandler analysts. They noted a mid-single-digit growth in loans, driven by commercial real estate activity, and a seasonal rise in deposit balances. Additionally, the net interest margin saw a slight increase to 2.96%, aligning with market predictions. Despite stable net interest income, the firm maintained robust capital levels and reported a decrease in net charge-offs, although nonperforming assets saw a slight increase. Piper Sandler responded to these earnings by raising Chemung Financial’s price target from $50 to $54, while maintaining a Neutral rating. The analyst firm emphasized the role of controlled expenses in the company’s positive performance and expressed a cautiously optimistic outlook. These developments are crucial for investors considering Chemung Financial’s future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.